Exhibit 107
Calculation of Filing Fee Tables
S-3
(Form Type)
Navidea Biopharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rate | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | ||||||||||||||||
Fees to be paid | Equity | Common Stock, par value $0.001 per share | 457(c) | 10,576,923 | (2) | $ | 0.080 | (3) | $ | 846,153.84 | (3) | 0.0001102 | $ | 93.25 | |||||||||
Total Offering Amount | $ | 846,153.84 | $ | 93.25 | |||||||||||||||||||
Fees Previously Paid | -- | $ | -- | ||||||||||||||||||||
Net Fee Due | $ | 93.25 | |||||||||||||||||||||
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares of common stock being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
(2) | Consists of shares of common stock registered for resale by the selling stockholders named in this registration statement issuable upon the conversion of Series J convertible preferred stock. |
(3) | Pursuant to Rule 457(c) under the Securities Act, calculated on the basis of the average of the high and low prices per share of the common stock reported on the NYSE American on August 24, 2023. |
